☰

Bulbul Pandit, Ph.D. - Publications

Affiliations: 
2007 Ohio State University, Columbus, Columbus, OH 
Area:
Pharmacology
Tree Info Similar researchers PubMed Report error

29 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Pandit B, Gartel AL. Mutual Regulation of FOXM1, NPM and ARF Proteins. Journal of Cancer. 6: 538-41. PMID 26000045 DOI: 10.7150/Jca.11766  0.352
2014 Halasi M, Pandit B, Gartel AL. Proteasome inhibitors suppress the protein expression of mutant p53. Cell Cycle (Georgetown, Tex.). 13: 3202-6. PMID 25485499 DOI: 10.4161/15384101.2014.950132  0.319
2013 Pandit B, Hu Z, Chettiar SN, Zink J, Xiao Z, Etter JP, Bhasin D, Li PK. Structure-activity relationship studies of thalidomide analogs with a taxol-like mode of action. Bioorganic & Medicinal Chemistry Letters. 23: 6902-4. PMID 24169233 DOI: 10.1016/J.Bmcl.2013.09.084  0.641
2013 Sun Y, Pandit B, Chettiar SN, Etter JP, Lewis A, Johnsamuel J, Li PK. Design, synthesis and biological studies of novel tubulin inhibitors. Bioorganic & Medicinal Chemistry Letters. 23: 4465-8. PMID 23790539 DOI: 10.1016/J.Bmcl.2013.04.078  0.735
2013 Halasi M, Pandit B, Wang M, Nogueira V, Hay N, Gartel AL. Combination of oxidative stress and FOXM1 inhibitors induces apoptosis in cancer cells and inhibits xenograft tumor growth. The American Journal of Pathology. 183: 257-65. PMID 23665201 DOI: 10.1016/J.Ajpath.2013.03.012  0.424
2011 Pandit B, Gartel AL. Proteasome inhibitors suppress expression of NPM and ARF proteins. Cell Cycle (Georgetown, Tex.). 10: 3827-9. PMID 22071628 DOI: 10.4161/Cc.10.22.18211  0.326
2011 Pandit B, Gartel AL. FoxM1 knockdown sensitizes human cancer cells to proteasome inhibitor-induced apoptosis but not to autophagy. Cell Cycle (Georgetown, Tex.). 10: 3269-73. PMID 21941087 DOI: 10.4161/Cc.10.19.17735  0.359
2011 Pandit B, Gartel AL. Thiazole antibiotic thiostrepton synergize with bortezomib to induce apoptosis in cancer cells. Plos One. 6: e17110. PMID 21365012 DOI: 10.1371/Journal.Pone.0017110  0.49
2011 Pandit B, Gartel AL. Proteasome inhibitors induce p53-independent apoptosis in human cancer cells. The American Journal of Pathology. 178: 355-60. PMID 21224072 DOI: 10.1016/J.Ajpath.2010.11.010  0.421
2011 Pandit B, Bhat UG, Gartel AL. Proteasome inhibitory activity of thiazole antibiotics. Cancer Biology & Therapy. 11: 43-7. PMID 21119308 DOI: 10.4161/Cbt.11.1.13854  0.391
2011 Pandit B, Wang M, Halasi M, Gartel AL. Abstract 2626: Thiazole antibiotic/proteasome inhibitor thiostrepton against cancer Cancer Research. 71: 2626-2626. DOI: 10.1158/1538-7445.Am2011-2626  0.529
2010 Mete E, Gul HI, Canturk P, Topcu Z, Pandit B, Gul M, Li PK. Biological activity of 1-aryl-3-phenethylamino-1-propanone hydrochlorides and 3-aroyl-4-aryl-1-phenethyl-4-piperidinols on PC-3 cells and DNA topoisomerase I enzyme. Zeitschrift FüR Naturforschung. C, Journal of Biosciences. 65: 647-52. PMID 21319705 DOI: 10.1515/Znc-2010-11-1203  0.706
2010 Bhat UG, Pandit B, Gartel AL. ARC synergizes with ABT-737 to induce apoptosis in human cancer cells. Molecular Cancer Therapeutics. 9: 1688-96. PMID 20515947 DOI: 10.1158/1535-7163.Mct-09-0919  0.429
2010 Lin L, Hutzen B, Zuo M, Ball S, Deangelis S, Foust E, Pandit B, Ihnat MA, Shenoy SS, Kulp S, Li PK, Li C, Fuchs J, Lin J. Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells. Cancer Research. 70: 2445-54. PMID 20215512 DOI: 10.1158/0008-5472.Can-09-2468  0.692
2010 Pandit B, Gartel AL. New potential anti-cancer agents synergize with bortezomib and ABT-737 against prostate cancer. The Prostate. 70: 825-33. PMID 20058240 DOI: 10.1002/Pros.21116  0.485
2010 Abdelhamid D, Corcoran M, Etter JP, Hu S, Pandit B, Li C, Li P, Fuchs JR. Abstract 4502: Synthesis and evaluation of curcumin-like compounds as inhibitors of the JAK/STAT pathway in cancer Cancer Research. 70: 4502-4502. DOI: 10.1158/1538-7445.Am10-4502  0.738
2010 Bhat U, Pandit B, Gartel AL. Abstract 1036: ARC synergizes with ABT-737 to induce apoptosis in human cancer cells Cancer Research. 70: 1036-1036. DOI: 10.1158/1538-7445.Am10-1036  0.436
2009 Pandit B, Halasi M, Gartel AL. p53 negatively regulates expression of FoxM1. Cell Cycle (Georgetown, Tex.). 8: 3425-7. PMID 19806025 DOI: 10.4161/Cc.8.20.9628  0.315
2009 Lin L, Hutzen B, Ball S, Foust E, Sobo M, Deangelis S, Pandit B, Friedman L, Li C, Li PK, Fuchs J, Lin J. New curcumin analogues exhibit enhanced growth-suppressive activity and inhibit AKT and signal transducer and activator of transcription 3 phosphorylation in breast and prostate cancer cells. Cancer Science. 100: 1719-27. PMID 19558577 DOI: 10.1111/J.1349-7006.2009.01220.X  0.695
2009 Fuchs JR, Pandit B, Bhasin D, Etter JP, Regan N, Abdelhamid D, Li C, Lin J, Li PK. Structure-activity relationship studies of curcumin analogues. Bioorganic & Medicinal Chemistry Letters. 19: 2065-9. PMID 19249204 DOI: 10.1016/J.Bmcl.2009.01.104  0.729
2008 Gul HI, Yerdelen KO, Das U, Gul M, Pandit B, Li PK, Dimmock JR. Synthesis and cytotoxicity of novel 3-aryl-1-(3'-dibenzylaminomethyl-4'-hydroxyphenyl)-propenones and related compounds. Chemical & Pharmaceutical Bulletin. 56: 1675-81. PMID 19043238 DOI: 10.1248/Cpb.56.1675  0.618
2008 Bhasin D, Cisek K, Pandharkar T, Regan N, Li C, Pandit B, Lin J, Li PK. Design, synthesis, and studies of small molecule STAT3 inhibitors. Bioorganic & Medicinal Chemistry Letters. 18: 391-5. PMID 18006313 DOI: 10.1016/J.Bmcl.2007.10.031  0.734
2007 de-Blanco EJ, Pandit B, Hu Z, Shi J, Lewis A, Li PK. Inhibitors of NF-kappaB derived from thalidomide. Bioorganic & Medicinal Chemistry Letters. 17: 6031-5. PMID 17845850 DOI: 10.1016/J.Bmcl.2007.01.088  0.684
2007 Gul HI, Yerdelen KO, Gul M, Das U, Pandit B, Li PK, Secen H, Sahin F. Synthesis of 4'-hydroxy-3'-piperidinomethylchalcone derivatives and their cytotoxicity against PC-3 cell lines. Archiv Der Pharmazie. 340: 195-201. PMID 17351963 DOI: 10.1002/Ardp.200600072  0.68
2006 Gul HI, Das U, Pandit B, Li PK. Evaluation of the cytotoxicity of some mono-mannich bases and their corresponding azine derivatives against androgen-independent prostate cancer cells. Arzneimittel-Forschung. 56: 850-4. PMID 17260673 DOI: 10.1055/S-0031-1296797  0.64
2006 Pandit B, Sun Y, Chen P, Sackett DL, Hu Z, Rich W, Li C, Lewis A, Schaefer K, Li PK. Structure-activity-relationship studies of conformationally restricted analogs of combretastatin A-4 derived from SU5416. Bioorganic & Medicinal Chemistry. 14: 6492-501. PMID 16860559 DOI: 10.1016/J.Bmc.2006.06.017  0.732
2006 Li PK, Pandit B, Sackett DL, Hu Z, Zink J, Zhi J, Freeman D, Robey RW, Werbovetz K, Lewis A, Li C. A thalidomide analogue with in vitro antiproliferative, antimitotic, and microtubule-stabilizing activities Molecular Cancer Therapeutics. 5: 450-456. PMID 16505120 DOI: 10.1158/1535-7163.Mct-05-0254  0.681
2005 Li PK, Xiao Z, Hu Z, Pandit B, Sun Y, Sackett DL, Werbovetz K, Lewis A, Johnsamuel J. Conformationally restricted analogs of Combretastatin A-4 derived from SU5416. Bioorganic & Medicinal Chemistry Letters. 15: 5382-5. PMID 16213720 DOI: 10.1016/J.Bmcl.2005.09.001  0.734
2003 Shi J, Xiao Z, Ihnat MA, Kamat C, Pandit B, Hu Z, Li PK. Structure-activity relationships studies of the anti-angiogenic activities of linomide. Bioorganic & Medicinal Chemistry Letters. 13: 1187-9. PMID 12643940 DOI: 10.1016/S0960-894X(03)00047-7  0.693
Show low-probability matches.